Gyre Therapeutics, Inc. SEC filings GYRE
Gyre Therapeutics, Inc. has 1,001 filings in SEC EDGAR's recent list, going back to Sep 10, 2013. Its latest annual report, Form ARS, was filed on Apr 27, 2026 for the period ended Dec 31, 2025. The latest quarterly report (Form 10-Q) was filed on Aug 7, 2026, covering the quarter ended Jun 30, 2026. The most recent current report (Form 8-K) was filed on Nov 5, 2026 (results of operations, regulation fd disclosure). The company's fiscal year ends on December 31.
| Form | Description | Filed | Period |
|---|---|---|---|
| 8-K |
Current report
Results of operations, Regulation FD disclosure
|
Nov 5, 2026 | Nov 5, 2026 |
| 8-K |
Current report
Officer or director change
|
Oct 22, 2026 | Oct 16, 2026 |
| 8-K |
Current report
Regulation FD disclosure
|
Sep 1, 2026 | Sep 1, 2026 |
| S-8 | Employee stock plan registration | Aug 27, 2026 | — |
| 8-K |
Current report
Regulation FD disclosure
|
Aug 26, 2026 | Aug 26, 2026 |
| 10-Q | Quarterly report | Aug 7, 2026 | Jun 30, 2026 |
| 8-K |
Current report
Results of operations
|
Aug 7, 2026 | Aug 7, 2026 |
| EFFECT | Filing | Aug 3, 2026 | — |
| 8-K |
Current report
Officer or director change, Regulation FD disclosure
|
Jul 16, 2026 | Jul 10, 2026 |
| 8-K/A |
Amended current report
Results of operations
|
Jul 15, 2026 | May 4, 2026 |
| S-3/A | Filing | Jul 13, 2026 | — |
| S-3 | Shelf registration | Jun 23, 2026 | — |
| 8-K |
Current report
Shareholder vote results
|
Jun 16, 2026 | Jun 10, 2026 |
| S-8 | Employee stock plan registration | Jun 10, 2026 | — |
| 8-K |
Current report
Regulation FD disclosure
|
Jun 2, 2026 | Jun 1, 2026 |
| 8-K |
Current report
Regulation FD disclosure
|
May 14, 2026 | May 14, 2026 |
| 8-K |
Current report
Regulation FD disclosure
|
May 12, 2026 | May 12, 2026 |
| 10-Q | Quarterly report | May 8, 2026 | Mar 31, 2026 |
| 8-K |
Current report
Results of operations
|
May 7, 2026 | May 7, 2026 |
| DEFA14A | Additional proxy material | May 4, 2026 | — |
| 8-K |
Current report
Acquisition or sale of assets, Unregistered share sale, Change to shareholder rights, Officer or director change, Bylaw or fiscal year change, Regulation FD disclosure
|
May 4, 2026 | May 4, 2026 |
| ARS | Annual report to shareholders | Apr 27, 2026 | Dec 31, 2025 |
| DEFA14A | Additional proxy material | Apr 27, 2026 | — |
| DEF 14A | Proxy statement | Apr 27, 2026 | Jun 10, 2026 |
| 8-K/A |
Amended current report
Material agreement
|
Apr 17, 2026 | Mar 2, 2026 |
| PRE 14A | Preliminary proxy statement | Apr 16, 2026 | Jun 10, 2026 |
| 8-K |
Current report
Other events
|
Mar 23, 2026 | Mar 22, 2026 |
| 10-K | Annual report | Mar 13, 2026 | Dec 31, 2025 |
| 8-K |
Current report
Regulation FD disclosure
|
Mar 12, 2026 | Mar 10, 2026 |
| 8-K |
Current report
Results of operations
|
Mar 12, 2026 | Mar 12, 2026 |
| 8-K |
Current report
Material agreement, Unregistered share sale, Officer or director change, Bylaw or fiscal year change, Regulation FD disclosure
|
Mar 2, 2026 | Mar 2, 2026 |
| 8-K |
Current report
Regulation FD disclosure
|
Jan 5, 2026 | Jan 5, 2026 |
| 10-Q | Quarterly report | Nov 7, 2025 | Sep 30, 2025 |
| 8-K |
Current report
Results of operations
|
Nov 7, 2025 | Nov 7, 2025 |
| 8-K |
Current report
Other events
|
Sep 10, 2025 | Sep 10, 2025 |
| 8-K |
Current report
Officer or director change, Regulation FD disclosure
|
Aug 22, 2025 | Aug 18, 2025 |
| 10-Q | Quarterly report | Aug 11, 2025 | Jun 30, 2025 |
| 8-K |
Current report
Results of operations, Officer or director change, Regulation FD disclosure
|
Aug 11, 2025 | Aug 5, 2025 |
| 8-K |
Current report
Shareholder vote results
|
Jun 6, 2025 | Jun 4, 2025 |
| 8-K |
Current report
Material agreement
|
May 23, 2025 | May 22, 2025 |
| 424B5 | Prospectus supplement | May 23, 2025 | — |
| 424B5 | Prospectus supplement | May 22, 2025 | — |
| 8-K |
Current report
Regulation FD disclosure, Other events
|
May 22, 2025 | May 22, 2025 |
| 10-Q | Quarterly report | May 9, 2025 | Mar 31, 2025 |
| 8-K |
Current report
Results of operations
|
May 9, 2025 | May 9, 2025 |
| 8-K |
Current report
Regulation FD disclosure
|
Apr 28, 2025 | Apr 28, 2025 |
| ARS | Annual report to shareholders | Apr 22, 2025 | Dec 31, 2024 |
| DEFA14A | Additional proxy material | Apr 21, 2025 | — |
| DEF 14A | Proxy statement | Apr 21, 2025 | Jun 4, 2025 |
| S-8 | Employee stock plan registration | Mar 20, 2025 | — |
| 10-K | Annual report | Mar 17, 2025 | Dec 31, 2024 |
| 8-K |
Current report
Results of operations
|
Mar 17, 2025 | Mar 17, 2025 |
| 8-K |
Current report
Results of operations, Regulation FD disclosure
|
Feb 18, 2025 | Feb 14, 2025 |
| 8-K |
Current report
Officer or director change, Regulation FD disclosure
|
Jan 6, 2025 | Dec 31, 2024 |
| 8-K |
Current report
Material agreement
|
Nov 27, 2024 | Nov 27, 2024 |
| 424B5 | Prospectus supplement | Nov 27, 2024 | — |
| EFFECT | Filing | Nov 22, 2024 | — |
| CORRESP | Letter to the SEC | Nov 20, 2024 | — |
| UPLOAD | Letter from the SEC | Nov 20, 2024 | — |
| S-3 | Shelf registration | Nov 14, 2024 | — |
| 10-Q | Quarterly report | Nov 13, 2024 | Sep 30, 2024 |
| 8-K |
Current report
Results of operations
|
Nov 13, 2024 | Nov 13, 2024 |
| 10-Q | Quarterly report | Aug 13, 2024 | Jun 30, 2024 |
| 8-K |
Current report
Results of operations
|
Aug 13, 2024 | Aug 13, 2024 |
| 8-K |
Current report
Officer or director change, Regulation FD disclosure, Other events
|
Aug 8, 2024 | Aug 6, 2024 |
| RW | Filing | Jul 12, 2024 | — |
| RW | Filing | Jul 12, 2024 | — |
| 8-K |
Current report
Listing notice, Officer or director change
|
Jul 5, 2024 | Jun 28, 2024 |
| 8-K |
Current report
Bylaw or fiscal year change, Shareholder vote results
|
Jun 17, 2024 | Jun 12, 2024 |
| S-3 | Shelf registration | May 30, 2024 | — |
| 8-K |
Current report
Regulation FD disclosure, Other events
|
May 30, 2024 | May 30, 2024 |
| S-3 | Shelf registration | May 30, 2024 | — |
| 10-Q | Quarterly report | May 13, 2024 | Mar 31, 2024 |
| 8-K |
Current report
Results of operations
|
May 9, 2024 | May 9, 2024 |
| 8-K |
Current report
Regulation FD disclosure, Other events
|
May 8, 2024 | May 7, 2024 |
| ARS | Annual report to shareholders | Apr 29, 2024 | Dec 31, 2023 |
| DEFA14A | Additional proxy material | Apr 29, 2024 | — |
| DEF 14A | Proxy statement | Apr 29, 2024 | Jun 12, 2024 |
| PRE 14A | Preliminary proxy statement | Apr 19, 2024 | Jun 12, 2024 |
| S-8 | Employee stock plan registration | Mar 28, 2024 | — |
| 10-K | Annual report | Mar 27, 2024 | Dec 31, 2023 |
| 8-K |
Current report
Listing notice
|
Mar 26, 2024 | Mar 22, 2024 |
| 8-K |
Current report
Results of operations
|
Mar 26, 2024 | Mar 26, 2024 |
| 8-K |
Current report
Officer or director change, Regulation FD disclosure
|
Mar 21, 2024 | Mar 20, 2024 |
| 8-K |
Current report
Results of operations, Regulation FD disclosure
|
Feb 14, 2024 | Feb 8, 2024 |
| 8-K/A |
Amended current report
Listing notice, Officer or director change
|
Jan 19, 2024 | Dec 11, 2023 |
| 8-K/A |
Amended current report
Acquisition or sale of assets
|
Jan 12, 2024 | Oct 30, 2023 |
| 8-K |
Current report
Officer or director change
|
Dec 15, 2023 | Dec 11, 2023 |
| 8-K |
Current report
Regulation FD disclosure
|
Dec 6, 2023 | Dec 6, 2023 |
| RW | Filing | Nov 29, 2023 | — |
| 8-K |
Current report
Regulation FD disclosure
|
Nov 14, 2023 | Nov 14, 2023 |
| D | Filing | Nov 13, 2023 | — |
| 8-K |
Current report
Regulation FD disclosure
|
Nov 13, 2023 | Nov 13, 2023 |
| S-3 | Shelf registration | Nov 13, 2023 | — |
| 8-K |
Current report
Regulation FD disclosure
|
Nov 6, 2023 | Nov 6, 2023 |
| 8-K |
Current report
Auditor change, Officer or director change
|
Nov 2, 2023 | Oct 30, 2023 |
| 424B3 | Prospectus | Nov 1, 2023 | — |
| S-8 | Employee stock plan registration | Oct 31, 2023 | — |
| 8-K |
Current report
Material agreement, Acquisition or sale of assets, Unregistered share sale, Change to shareholder rights, Change in control, Officer or director change, Bylaw or fiscal year change, Regulation FD disclosure
|
Oct 30, 2023 | Oct 27, 2023 |
| EFFECT | Filing | Oct 27, 2023 | — |
| 8-K |
Current report
Regulation FD disclosure
|
Oct 27, 2023 | Oct 26, 2023 |
| 424B3 | Prospectus | Oct 27, 2023 | — |
| 10-Q | Quarterly report | Oct 26, 2023 | Sep 30, 2023 |
| CORRESP | Letter to the SEC | Oct 24, 2023 | — |
| S-3/A | Form s-3/a | Oct 24, 2023 | — |
| 8-K |
Current report
Other events
|
Oct 23, 2023 | Oct 20, 2023 |
| CORRESP | Letter to the SEC | Oct 13, 2023 | — |
| S-3/A | Filing | Oct 13, 2023 | — |
| 8-K |
Current report
Material agreement, Change to shareholder rights, Bylaw or fiscal year change, Shareholder vote results, Other events
|
Aug 31, 2023 | Aug 29, 2023 |
| 10-Q | Quarterly report | Aug 14, 2023 | Jun 30, 2023 |
| 8-K |
Current report
Results of operations
|
Aug 14, 2023 | Aug 14, 2023 |
| UPLOAD | Letter from the SEC | Aug 3, 2023 | — |
| S-3 | Shelf registration | Jul 24, 2023 | — |
| UPLOAD | Letter from the SEC | Jul 20, 2023 | — |
| DEFM14A | Form defm14a | Jul 20, 2023 | — |
| CORRESP | Letter to the SEC | Jul 12, 2023 | — |
| PRER14A | Filing | Jul 12, 2023 | — |
| UPLOAD | Letter from the SEC | Jul 10, 2023 | — |
| CORRESP | Letter to the SEC | Jun 26, 2023 | — |
| PRER14A | Filing | Jun 26, 2023 | — |
| DEFA14A | Additional proxy material | Jun 20, 2023 | — |
| 8-K |
Current report
Change to shareholder rights, Bylaw or fiscal year change
|
Jun 20, 2023 | Jun 20, 2023 |
| UPLOAD | Letter from the SEC | May 31, 2023 | — |
| 10-Q | Quarterly report | May 15, 2023 | Mar 31, 2023 |
| CORRESP | Letter to the SEC | May 15, 2023 | — |
| PRER14A | Filing | May 15, 2023 | — |
| DEFA14A | Additional proxy material | May 5, 2023 | — |
| 8-K |
Current report
Listing notice
|
May 5, 2023 | May 2, 2023 |
| UPLOAD | Letter from the SEC | Apr 27, 2023 | — |
| DEFA14A | Additional proxy material | Apr 7, 2023 | — |
| 8-K |
Current report
Listing notice
|
Apr 7, 2023 | Apr 4, 2023 |
| PREM14A | Filing | Mar 30, 2023 | Mar 30, 2023 |
| DEFA14A | Additional proxy material | Mar 30, 2023 | — |
| 8-K |
Current report
Material agreement
|
Mar 30, 2023 | Mar 29, 2023 |
| 10-K | Annual report | Mar 30, 2023 | Dec 31, 2022 |
| DEFA14A | Additional proxy material | Mar 21, 2023 | — |
| 8-K |
Current report
Regulation FD disclosure
|
Mar 21, 2023 | Mar 20, 2023 |
| DEFA14A | Additional proxy material | Mar 2, 2023 | — |
| 8-K |
Current report
Material agreement, Acquisition or sale of assets, Other events
|
Mar 2, 2023 | Feb 27, 2023 |
| 8-K |
Current report
Officer or director change
|
Jan 19, 2023 | Jan 15, 2023 |
| 425 | Filing | Dec 27, 2022 | — |
| 8-K |
Current report
Material agreement, Acquisition or sale of assets, Unregistered share sale, Officer or director change, Bylaw or fiscal year change, Regulation FD disclosure, Other events
|
Dec 27, 2022 | Dec 22, 2022 |
| 10-Q | Quarterly report | Nov 14, 2022 | Sep 30, 2022 |
| 8-K |
Current report
Listing notice
|
Nov 4, 2022 | Nov 2, 2022 |
| 8-K |
Current report
Other events
|
Aug 25, 2022 | Aug 25, 2022 |
| 8-K |
Current report
Other events
|
Aug 19, 2022 | Aug 18, 2022 |
| 8-K |
Current report
Shareholder vote results
|
Aug 15, 2022 | Aug 15, 2022 |
| 8-K |
Current report
Results of operations
|
Aug 15, 2022 | Aug 15, 2022 |
| 10-Q | Quarterly report | Aug 15, 2022 | Jun 30, 2022 |
| DFAN14A | Filing | Aug 11, 2022 | — |
| DEFA14A | Additional proxy material | Aug 10, 2022 | — |
| DEFA14A | Additional proxy material | Aug 4, 2022 | — |
| DFAN14A | Filing | Aug 3, 2022 | — |
| DEFA14A | Additional proxy material | Aug 3, 2022 | — |
| DEFA14A | Additional proxy material | Aug 1, 2022 | — |
| 8-K |
Current report
Other events
|
Aug 1, 2022 | Jul 31, 2022 |
| DEFA14A | Additional proxy material | Aug 1, 2022 | — |
| DEFA14A | Additional proxy material | Jul 29, 2022 | — |
| DFAN14A | Filing | Jul 28, 2022 | — |
| DFAN14A | Filing | Jul 22, 2022 | — |
| DFAN14A | Filing | Jul 22, 2022 | — |
| DFAN14A | Filing | Jul 21, 2022 | — |
| DEFC14A | Filing | Jul 19, 2022 | — |
| DEFC14A | Filing | Jul 19, 2022 | — |
| DEFA14A | Additional proxy material | Jul 19, 2022 | — |
| PRRN14A | Filing | Jul 18, 2022 | — |
| UPLOAD | Letter from the SEC | Jul 18, 2022 | — |
| PRRN14A | Filing | Jul 14, 2022 | — |
| 8-K |
Current report
Regulation FD disclosure
|
Jul 11, 2022 | Jul 11, 2022 |
| PREC14A | Filing | Jul 8, 2022 | — |
| DEFA14A | Additional proxy material | Jul 6, 2022 | — |
| DEFA14A | Additional proxy material | Jun 29, 2022 | — |
| DEFA14A | Additional proxy material | Jun 28, 2022 | — |
| 8-K |
Current report
Other events
|
Jun 27, 2022 | Jun 24, 2022 |
| DFAN14A | Filing | Jun 17, 2022 | — |
| DEFA14A | Additional proxy material | Jun 9, 2022 | — |
| 8-K |
Current report
Other events
|
Jun 9, 2022 | Jun 7, 2022 |
| DFAN14A | Filing | May 25, 2022 | — |
| 8-K/A | Amended current report | May 24, 2022 | May 19, 2022 |
| 8-K |
Current report
Material agreement, Acquisition or sale of assets
|
May 23, 2022 | May 19, 2022 |
| DFAN14A | Filing | May 10, 2022 | — |
| PRRN14A | Filing | May 9, 2022 | — |
| 8-K |
Current report
Results of operations
|
May 9, 2022 | May 9, 2022 |
| 10-Q | Quarterly report | May 9, 2022 | Mar 31, 2022 |
| UPLOAD | Letter from the SEC | May 4, 2022 | — |
| DFAN14A | Filing | May 2, 2022 | — |
| 10-K/A | Amended annual report | May 2, 2022 | Dec 31, 2021 |
| PREC14A | Filing | Apr 28, 2022 | — |
| DFAN14A | Filing | Apr 21, 2022 | — |
| 8-K |
Current report
Results of operations, Exit or restructuring costs, Officer or director change
|
Apr 5, 2022 | Mar 31, 2022 |
| S-8 | Employee stock plan registration | Mar 31, 2022 | — |
| 10-K | Annual report | Mar 31, 2022 | Dec 31, 2021 |
| DFAN14A | Filing | Mar 16, 2022 | — |
| 8-K |
Current report
Agreement ended
|
Mar 16, 2022 | Mar 10, 2022 |
| DFAN14A | Filing | Mar 7, 2022 | — |
| DFAN14A | Filing | Feb 28, 2022 | — |
| DFAN14A | Filing | Feb 23, 2022 | — |
| 8-K |
Current report
Listing notice
|
Feb 18, 2022 | Feb 16, 2022 |
| 8-K |
Current report
Other events
|
Jan 25, 2022 | Jan 25, 2022 |
| 8-K |
Current report
Regulation FD disclosure
|
Jan 12, 2022 | Jan 12, 2022 |
Showing 200 filings, the most recent 200. Main filings leave out insider and ownership forms such as Form 4; choose a type above to see them. Each form opens on SEC.gov. Older filings are on SEC EDGAR.
New to this? Read What Are SEC Filings? 10-K, 10-Q, 8-K and Other Forms Explained.
Company profile
- Industry
- Pharmaceutical Preparations (SIC 2834)
- Listed as
- GYRE (Nasdaq)
- Fiscal year ends
- December 31
- Incorporated in
- DE
- Headquarters
- San Diego, CA
- SEC filer status
- Accelerated filer, Smaller reporting company
- SEC CIK
- 1124105
- Former names
- CATALYST BIOSCIENCES, INC. (until Oct 27, 2023); TARGACEPT INC (until Aug 19, 2015)
Other Pharmaceutical Preparations companies
- ELI LILLY & Co LLY
- Johnson & Johnson JNJ
- AbbVie Inc. ABBV
- Merck & Co., Inc. MRK
- Novartis AG NVS
- Astrazeneca PLC AZN
- Abbott Laboratories ABT
- Novo Nordisk A S NVO
Source: SEC EDGAR filings. This is company-reported data, not investment advice.